Dr. Daruka Mahadevan named director of the Institute for Drug Development
October 7, 2020
Daruka Mahadevan, MD, PhD, chief of the Division of Hematology-Oncology, was appointed to two new expanded leadership roles at the Mays Cancer Center. In addition to being chief of hematology-oncology, Dr. Mahadevan will assume the roles of director of the Institute for Drug Development and associate director for clinical research. Dr. Mahadevan is a world-renowned expert in […]